Related Experiment Video
Updated: May 3, 2026

12:26
In Vivo Direct Reprogramming of Resident Glial Cells into Interneurons by Intracerebral Injection of Viral Vectors
Published on: June 17, 2019
10.0K
Dynamic regulation of NeuroD1 expression level by a novel viral construct during astrocyte-to-neuron reprogramming
Natalie Mseis-Jackson1, Mei Jiang1, Mehek Sharma2
1Department of Neuroscience & Regenerative Medicine, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
Molecular Therapy. Nucleic Acids
|October 2, 2025
Summary
This study engineered a novel vector for astrocyte-to-neuron reprogramming. It dynamically reduces NeuroD1 expression, enhancing GABAergic neuron generation for regenerative medicine.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Molecular Biology
Background:
- Astrocyte-to-neuron reprogramming is promising for regenerative medicine.
- The NeuroD1 factor efficiently reprograms cells but primarily to glutamatergic neurons.
- Generating diverse neuronal subtypes is crucial for functional neural circuits.
Purpose of the Study:
- To develop a method for generating diverse neuronal subtypes from astrocytes.
- To investigate if dynamic regulation of NeuroD1 expression can diversify neuronal subtypes.
- To engineer a novel viral vector for controlled NeuroD1 expression.
Main Methods:
- Engineered a viral expression vector with a miR-124 target site for dynamic NeuroD1 regulation.
- Utilized astrocyte-to-neuron reprogramming in vitro.
- Analyzed gene expression patterns and neuronal phenotypes.
Main Results:
- The novel construct achieved dynamic NeuroD1 expression, decreasing at later stages.
- Reprogramming efficiency remained high.
- Generated mature neurons with an enhanced GABAergic phenotype.
Conclusions:
- Dynamic NeuroD1 regulation via miR-124 targeting enables generation of diverse neuronal subtypes.
- This approach enhances GABAergic neuron production, crucial for neural circuit restoration.
- Offers a refined strategy for regenerative medicine applications.
Keywords:
MT: Oligonucleotides: Therapies and ApplicationsNeuroD1astrocytemiR-124microRNAneuronal reprogramming
